Our library of clinical trials information is updated regularly from the US government database on clinical trials, so you can be assured that new zelmac clinical trials listings will be included here shortly after becoming available to us.
Related Sponsors
Clinical Trials on zelmac
- A Randomized, Double-Blind, Placebo-Controlled Multicenter Study to Assess the Efficacy, Safety and Tolerability of Tegaserod 2 mg Bid vs Placebo in Patients With Chronic Constipation
Status: Terminated, Condition Summary: Constipation; Chronic Disease - Study of Effect of Tegaserod on Small and Large Bowel Transit by Scintigraphic Method
Status: Recruiting, Condition Summary: Constipation - A Treatment Investigational New Drug (tIND) Program of Tegaserod in Women With Irritable Bowel Syndrome With Constipation or With Chronic Idiopathic Constipation
Status: No longer available, Condition Summary: Irritable Bowel Syndrome With Constipation; Chronic Idiopathic Constipation - The Effect of Tegaserod on Patterns of Flow in the Small Bowel of Patients With Irritable Bowel Syndrome (IBS)
Status: Terminated, Condition Summary: Constipation Predominant - Irritable Bowel Syndrome (IBS-C) - Assessment of the Effect of Tegaserod (2 mg Tid and 6 mg Tid) on Dyspeptic Symptoms in Diabetic Patients With Symptoms of Diabetic Gastropathy
Status: Terminated, Condition Summary: Diabetic Gastropathy - Safety and Efficacy of Tegaserod in Opioid-Induced Constipation in Patients With Non-Cancer Pain.
Status: Terminated, Condition Summary: Opioid-Induced Constipation - Safety and Efficacy of Tegaserod in Opioid-Induced Constipation in Patients With Non-Cancer Pain.
Status: Terminated, Condition Summary: Opioid-Induced Constipation - Effect of Tegaserod on Orocecal Transit in Elderly Chronic Constipation Patients
Status: Terminated, Condition Summary: Chronic Constipation - Efficacy and Safety of Tegaserod in Opioid-Induced Constipation in Patients With Non-Cancer Pain
Status: Terminated, Condition Summary: Constipation - Effect of Tegaserod on Gastric Emptying in Patients With Diabetic Gastroparesis
Status: Terminated, Condition Summary: Gastroparesis; Diabetes - The Role of Tegaserod Therapy in the Management of Dyspeptic Symptoms in Female Patients on Proton Pump Inhibitors for the Treatment of Heartburn.
Status: Completed, Condition Summary: Dyspepsia - An Evaluation of the Efficacy and Safety of Tegaserod 6 mg Bid Given Orally to Chinese Patients With Chronic Constipation
Status: Completed, Condition Summary: Constipation - Preference of Tegaserod vs. PEG 3350 in Patients With Constipation
Status: Completed, Condition Summary: Constipation - Assessment of Efficacy and Safety of Tegaserod Treatment and Placebo in Women With Dyspepsia
Status: Completed, Condition Summary: Dyspepsia - Efficacy, Safety and Tolerability of Tegaserod in Patients With Chronic Constipation
Status: Completed, Condition Summary: Chronic Constipation - Extension Study to Assess the Long-Term Safety of Tegaserod in Women With Symptoms of Dyspepsia
Status: Completed, Condition Summary: Dyspepsia - Assessment of Efficacy and Safety of Tegaserod in Male Patients With Chronic Constipation.
Status: Completed, Condition Summary: Chronic Constipation - Assessment of Efficacy and Safety of Tegaserod Treatment and Placebo in Women With Dyspepsia
Status: Completed, Condition Summary: Dyspepsia - Extension Study to Assess the Long-Term Safety of Tegaserod in Women With Symptoms of Dyspepsia
Status: Completed, Condition Summary: Dyspepsia - Efficacy of Tegaserod in Relieving the Symptoms of Female Patients With Irritable Bowel Syndrome (IBS), Excluding Those With Predominant Diarrhea IBS
Status: Completed, Condition Summary: IBS-C and IBS With Mixed Bowel Habits - Assessment of the Effects of Tegaserod in the Management of Gastroesophageal Reflux Disease (GERD) in Patients With Incomplete Response to Proton Pump Inhibitors (PPIs).
Status: Completed, Condition Summary: Gastroesophageal Reflux Disease (GERD) - A Study to Assess the Efficacy, Safety and Tolerability of Tegaserod Alone and in Combination With Omeprazole Given Orally in Patients With Symptoms of Symptomatic Gastroesophageal Reflux Disease (sGERD)
Status: Completed, Condition Summary: Symptomatic Gastroespohageal Reflux Disease - Assessment of the Role of Tegaserod Therapy in the Management of Gastroesophageal Reflux Disease (GERD) Symptoms in Patients With Incomplete Response to Proton Pump Inhibitors (PPIs).
Status: Completed, Condition Summary: Gastroesophageal Reflux Disease (GERD) - The Effects of Tegaserod on Mechanical Sensitivity of the Esophagus and Stomach in Patients With Heartburn and Dyspepsia.
Status: Completed, Condition Summary: Heartburn; Dyspepsia - The Effects of Tegaserod Vs. Placebo on Whole Gut Transit Time in Patients With Chronic Constipation and Dyspepsia
Status: Withdrawn, Condition Summary: Constipation and Dyspepsia - Polyethyleneglycol3350 Vs Tegaserod in Treatment of Patients With Chronic Constipation
Status: Completed, Condition Summary: Constipation